Mosquitoes that can transmit dangerous viruses are now a year-round threat to Miami-Dade County, according to a new study led by University of Miami Miller School of Medicine public health researchers who collaborated with the county’s Mosquito Control Division.
The Burnstein lab at Sylvester Comprehensive Cancer Center, along with collaborators at Moffitt Cancer Center and the University of Florida Cancer Center, recently discovered that arginine vasopressin receptor type 1a (AVPR1a) can promote aggressive prostate cancer growth.
An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller School of Medicine researcher. The current phase III trial builds upon the results of a prior phase II trial that enrolled patients with a rapidly progressive, rare genetic form of ALS.
Akram Tamer, M.D., came to the University of Miami in 1969 as a resident seeking to advance his knowledge of pediatrics. Through the years, he has cared for young patients and families, conducted significant research and inspired several generations of students, residents and faculty at the Miller School of Medicine through his teaching.
A group of researchers from Sylvester Comprehensive Cancer Center, the Department of Surgery and the Department of Medicine at the University of Miami Miller School of Medicine have found that probiotics can reduce morphine tolerance when used as an adjunct therapy in germ-free mice.